News | July 22, 2014

SCAI Publishes Expert Consensus Recommendations for Treating Below-the-Knee Peripheral Artery Disease

July 22, 2014 -- The incidences of obesity and diabetes are increasing, and with them the number of patients with peripheral artery disease (PAD) in the arteries of the limbs. A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SCAI) will help physicians determine the best course of action for patients whose blockages reduce blood flow to their limbs, putting them at risk for gangrene and amputation. The third paper in the series, e-published in Catheterization and Cardiovascular Interventions, outlines recommendations for treating infrapopliteal (IP), or “below-the-knee,” arterial disease.
 
Elderly patients and those with long-standing diabetes or chronic kidney disease are at greatest risk of developing such blockages, which can progress to critical limb ischemia (CLI), a painful and chronic condition that can lead to amputation. As the population ages and the number of patients with diabetes rises, the rate of CLI is expected to increase.
 
“Treating patients with IP arterial disease and CLI can relieve pain, heal ulcerations, preserve limbs and improve quality of life and function,” said Bruce H. Gray, D.O., FSCAI, professor of surgery/vascular medicine, University of South Carolina School of Medicine, and lead author of the consensus paper. “Depending on the patient’s condition, open surgery, an endovascular intervention or amputation are considered appropriate courses of action. These new recommendations aim to help guide physicians to make the best care decisions when an endovascular approach is appropriate.” 
 
The expert panel reviewed scientific data on each CLI treatment option, including balloon angioplasty, stents, atherectomy, as well as experimental therapies such as drug-coated balloons.Patients with severe disease, those with pain at rest and those with minor or major tissue loss should be considered for revascularization, with either surgery or endovascular treatment to prevent amputation or improve healing following amputation. Currently there is insufficient evidence to support treatment in those with asymptomatic disease.This document is the latest in SCAI’s series of recommendations for treating PAD. Previous documents included “SCAI Expert Consensus Document for Aorto-Iliac Arterial Intervention Appropriate Use” and “SCAI Expert Consensus Document for Femoral-Popliteal Arterial Intervention Appropriate Use.” The final document in the series will focus on renal artery stenosis and will be published in Catheterization and Cardiovascular Interventions later this summer.
 
“SCAI is committed to providing physicians with the necessary tools to appropriately diagnose and treat patients,” said SCAI 2014-15 President Charles Chambers, M.D., FSCAI. “These recommendations were developed based on our belief that patient safety and quality should always be physicians’ top priority.” The paper, titled “SCAI Expert Consensus Statement for Infrapopliteal Arterial Intervention Appropriate Use,” is e-published in Catheterization and Cardiovascular Interventions.
 
For more information: www.SCAI.org

Related Content

Lithotripsy Safe and Effective in Calcified Stenotic Peripheral Arteries
News | Peripheral Artery Disease (PAD) | December 04, 2018
New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt closures with the...
Lutonix 014 Drug-Coated Balloon Safe and Effective Below the Knee
News | Peripheral Artery Disease (PAD) | November 07, 2018
The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous...
Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018
NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai Medical, a specialty...
PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018
The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long blockages in the...
SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection
News | Peripheral Artery Disease (PAD) | May 15, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the...
SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and...
Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018
Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence of faster wound...
FDA Clears Corindus CorPath GRX for Peripheral Vascular Interventions
Technology | Peripheral Artery Disease (PAD) | February 20, 2018
Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the U.S. Food and Drug...
News | Peripheral Artery Disease (PAD) | December 29, 2017
December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (
Overlay Init